Company Filing History:
Years Active: 2018
Title: Aiko Itoh: Innovator in Protein Engineering
Introduction
Aiko Itoh is a prominent inventor based in Kagawa, Japan. She has made significant contributions to the field of protein engineering, particularly through her innovative work on galectin-9 variants. Her research focuses on enhancing the stability and solubility of proteins, which has important implications for various biomedical applications.
Latest Patents
Aiko Itoh holds 1 patent for her invention titled "Modified galectin-9 protein." This patent presents a galectin-9 variant that maintains substantially the same bioactivity as the wild-type galectin-9 while exhibiting superior protease stability, solubility, and yield. The invention details a protein that includes specific N-terminal and C-terminal regions, with the C terminus of the N-terminal region and the N terminus of the C-terminal region being directly or indirectly bound to each other. The NCRD is a peptide composed of an amino acid sequence represented by SEQ ID NO: 1, while the N-terminal region of the CCRD is a peptide obtained by deleting 1 to 17 amino acids from an amino acid sequence represented by SEQ ID NO: 3. The C-terminal region is also defined by a specific amino acid sequence represented by SEQ ID NO: 5.
Career Highlights
Aiko Itoh is affiliated with Kagawa University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential applications in therapeutic development and protein design.
Collaborations
Aiko collaborates with Nozomu Nishi, who is also involved in research related to protein engineering. Their partnership enhances the scope and impact of their work in the field.
Conclusion
Aiko Itoh's innovative contributions to protein engineering, particularly through her work on modified galectin-9 proteins, highlight her role as a leading inventor in this specialized area. Her research continues to pave the way for advancements in biomedical applications.